JSM6427

· Jerini Ophthalmic

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JSM6427, covering 2010-09-21 to 2010-09-21. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Safety Study of Single and Repeated Doses of JSM6427 (Intravitreal Injection) to Treat AMD [Phase 1]